Psychiatry and Neurology, Neurology · Watertown, NY
NPI
1871535948
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1340 Washington St
Watertown, NY, 13601
Phone (315) 782-9003
Groups this clinician bills Medicare through
Medicare paid, 2024
$205K
4,028 services
Medicare patients, 2024
733
Average age 72
Drug cost, 2024
$1.9M
4,924 prescriptions
Company payments, 2025
$18.23
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Abdul Latif was code A9579 (injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml), 2,035 times for 109 patients. In total Abdul Latif billed 4,028 services in 33 codes, and Medicare paid $205K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-31.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | Office | 2,035 | 109 | $1.15 | $2,334 |
| 99214 Office E&M - Established | Office | 356 | 193 | $86.59 | $31K |
| 70551 MRI/MRA - Head and Neck | Office | 254 | 243 | $98.67 | $25K |
| 95886 Electrical Nerve Conductivity | Office | 233 | 129 | $77.62 | $18K |
| 70544 MRI/MRA - Head and Neck | Office | 215 | 188 | $125.62 | $27K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 213 | 161 | $12.61 | $2,685 |
| 70547 MRI/MRA - Head and Neck | Office | 184 | 163 | $130.64 | $24K |
| 70553 MRI/MRA - Head and Neck | Office | 101 | 94 | $161.89 | $16K |
| 95913 Electrical Nerve Conductivity | Office | 91 | 84 | $221.79 | $20K |
| 72141 MRI/MRA - Spine | Office | 78 | 77 | $92.58 | $7,221 |
| 95887 Electrical Nerve Conductivity | Office | 60 | 57 | $66.45 | $3,987 |
| 72148 MRI/MRA - Spine | Office | 60 | 60 | $97.10 | $5,826 |
| 95911 Electrical Nerve Conductivity | Office | 45 | 42 | $167.67 | $7,545 |
| 72156 MRI/MRA - Spine | Office | 19 | 18 | $177.81 | $3,378 |
| 72146 MRI/MRA - Spine | Office | 18 | 17 | $104.50 | $1,881 |
By year: 2022 $226K for 4,427 services; 2023 $217K for 4,365 services; 2024 $205K for 4,028 services.
Medicare prescription drug claims, 2024
In 2024, the drug Abdul Latif prescribed most often to Medicare patients was Ropinirole Hcl, with 323 prescriptions and refills. In total Abdul Latif wrote 4,924 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ropinirole Hcl Generic | 323 | 491 | 55 | $6,862 |
| Gabapentin Generic | 321 | 487 | 58 | $4,609 |
| Topiramate Generic | 201 | 319 | 30 | $1,575 |
| Zonisamide Generic | 189 | 248 | 29 | $2,154 |
| Baclofen Generic | 186 | 310 | 32 | $4,380 |
| Primidone Generic | 167 | 251 | 28 | $4,083 |
| Nortriptyline Hcl Generic | 164 | 236 | 23 | $1,714 |
| Levetiracetam Generic | 144 | 244 | 24 | $2,855 |
| Memantine Hcl Generic | 137 | 167 | 18 | $1,663 |
| Aimovig Autoinjector Erenumab-Aooe | 132 | 162 | 19 | $122K |
| Tizanidine Hcl Generic | 131 | 158 | 22 | $2,058 |
| Lamotrigine Generic | 129 | 182 | 16 | $1,863 |
| Divalproex Sodium Generic | 119 | 177 | 21 | $2,619 |
| Pregabalin Generic | 116 | 120 | 18 | $4,102 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 111 | 153 | 14 | $3,640 |
Brand drugs: 638 claims; generic drugs: 4,257 claims; opioid claims: 117.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abdul Latif $18.23 ($18.23 in general payments such as food, travel and fees) from 1 company. The largest payer was Pfizer Inc. with $18.23.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 1 | $18.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.